Page 190 - Read Online

Chen et al. Mini-invasive Surg 2018;2:42 I http://dx.doi.org/10.20517/2574-1225.2018.59 Page 17 of 17

39. Allaix ME, Rebecchi F, Giaccone C, Mistrangelo M, Morino M. Long-term functional results and quality of life after transanal
endoscopic microsurgery. Br J Surg 2011;98:1635-43.
40. Jakubauskas M, Jotautas V, Poskus E, Mikalauskas S, Valeikaite-Tauginiene G, et al. Fecal incontinence after transanal endoscopic
microsurgery. Int J Colorectal Dis 2018;33:467-72.
41. Hompes R, Ashraf SQ, Gosselink MP, van Dongen KW, Mortensen NJ, et al. Evaluation of quality of life and function at 1 year after
transanal endoscopic microsurgery. Colorectal Dis 2015;17:O54-61.
42. D'Ambrosio G, Paganini AM, Balla A, Quaresima S, Ursi P, et al. Quality of life in non-early rectal cancer treated by neoadjuvant radio-
chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total
mesorectal excision. Surg Endosc 2016;30:504-11.
43. Verseveld M, Barendse RM, Gosselink MP, Verhoef C, de Graaf EJ, et al. Transanal minimally invasive surgery: impact on quality of
life and functional outcome. Surg Endosc 2016;30:1184-7.
44. García-Flórez LJ, Otero-Díez JL, Encinas-Muñiz AI, Sánchez-Domínguez L. Indications and outcomes from 32 consecutive patients for
the treatment of rectal lesions by transanal minimally invasive surgery. Surg Innov 2017;24:336-42.
45. Clermonts SHEM, van Loon YT, Wasowicz DK, Langenhoff BS, Zimmerman DDE. Comparative quality of life in patients following
transanal minimally invasive surgery and healthy control subjects. J Gastrointest Surg 2018;22:1089-97.
46. Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and
laparoscopic assistance. Surg Endosc 2010;24:1205-10.
47. Lee GC, Sylla P. Shifting paradigms in minimally invasive surgery: applications of transanal natural orifice transluminal endoscopic
surgery in colorectal surgery. Clin Colon Rectal Surg 2015;28:181-93.
48. Rasulov AO, Mamedli ZZ, Gordeyev SS, Kozlov NA, Dzhumabaev HE. Short-term outcomes after transanal and laparoscopic total
mesorectal excision for rectal cancer. Tech Coloproctol 2016;20:227-34.
49. Chang TC, Kiu KT. Kiu. Transanal total mesorectal excision in lower rectal cancer: comparison of short-term outcomes with
conventional laparoscopic total mesorectal excision. J Laparoendosc Adv Surg Tech A 2018;28:365-9.
50. Atallah SB, DuBose AC, Burke JP, Nassif G, deBeche-Adams T, et al. Uptake of transanal total mesorectal excision in North America:
initial assessment of a structured training program and the experience of delegate surgeons. Dis Colon Rectum 2017;60:1023-31.
51. Maykel JA. Comprehensive training and safe implementation of a transanal total mesorectal excision program. Dis Colon Rectum
2017;60:995-6.
52. Maykel JA, Phatak UR, Suwanabol PA, Schlussel AT, Davids JS, et al. Initiation of a transanal total mesorectal excision program at an
academic training program: evaluating patient safety and quality outcomes. Dis Colon Rectum 2017;60:1267-72.
53. Koedam TW, van Ramshorst GH, Deijen CL, Elfrink AK, Meijerink WJ, et al. Transanal total mesorectal excision (TaTME) for rectal
cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol 2017;21:25-33.
54. Veltcamp Helbach M, Koedam TWA, Knol JJ, Velthuis S, Bonjer HJ, et al. Quality of life after rectal cancer surgery: differences
between laparoscopic and transanal total mesorectal excision. Surg Endosc 2018; doi: 10.1007/s00464-018-6276-z.
55. Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, et al. COLOR III: a multicentre randomised clinical trial comparing
transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc 2016;30:3210-5.
56. Serra-Aracil X, Zárate A, Mora L, Serra-Pla S, Pallisera A, et al. Study protocol for a multicenter prospective controlled and randomized
trial of transanal total mesorectal excision versus laparoscopic low anterior resection in rectal cancer. Int J Colorectal Dis 2018;33:649-
55.
57. Damle A, Damle RN, Flahive JM, Schlussel AT, Davids JS, et al. Diffusion of technology: trends in robotic-assisted colorectal surgery.
Am J Surg 2017;214:820-4.
58. Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, et al. Organ preservation in rectal adenocarcinoma: a phase II randomized
controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus
induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC Cancer 2015;15:767.
59. Habr-Gama A, Lynn PB, Jorge JM, São Julião GP, Proscurshim I, et al. Impact of organ-preserving strategies on anorectal function in
patients with distal rectal cancer following neoadjuvant chemoradiation. Dis Colon Rectum 2016;59:264-9.
60. Hupkens BJP, Martens MH, Stoot JH, Berbee M, Melenhorst J, et al. Quality of life in rectal cancer patients after chemoradiation:
watch-and-wait policy versus standard resection - a matched-controlled study. Dis Colon Rectum 2017;60:1032-40.